A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling.


Journal

Nature cancer
ISSN: 2662-1347
Titre abrégé: Nat Cancer
Pays: England
ID NLM: 101761119

Informations de publication

Date de publication:
03 2023
Historique:
received: 06 02 2022
accepted: 03 01 2023
medline: 29 3 2023
pubmed: 3 2 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

Metabolic rewiring is often considered an adaptive pressure limiting metastasis formation; however, some nutrients available at distant organs may inherently promote metastatic growth. We find that the lung and liver are lipid-rich environments. Moreover, we observe that pre-metastatic niche formation increases palmitate availability only in the lung, whereas a high-fat diet increases it in both organs. In line with this, targeting palmitate processing inhibits breast cancer-derived lung metastasis formation. Mechanistically, breast cancer cells use palmitate to synthesize acetyl-CoA in a carnitine palmitoyltransferase 1a-dependent manner. Concomitantly, lysine acetyltransferase 2a expression is promoted by palmitate, linking the available acetyl-CoA to the acetylation of the nuclear factor-kappaB subunit p65. Deletion of lysine acetyltransferase 2a or carnitine palmitoyltransferase 1a reduces metastasis formation in lean and high-fat diet mice, and lung and liver metastases from patients with breast cancer show coexpression of both proteins. In conclusion, palmitate-rich environments foster metastases growth by increasing p65 acetylation, resulting in a pro-metastatic nuclear factor-kappaB signaling.

Identifiants

pubmed: 36732635
doi: 10.1038/s43018-023-00513-2
pii: 10.1038/s43018-023-00513-2
pmc: PMC7615234
mid: EMS172138
doi:

Substances chimiques

NF-kappa B 0
Carnitine O-Palmitoyltransferase EC 2.3.1.21
Acetyl Coenzyme A 72-89-9
Palmitates 0
Lysine Acetyltransferases EC 2.3.1.32

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

344-364

Subventions

Organisme : Arthritis Research UK
ID : FC001112
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC001112
Pays : United Kingdom
Organisme : European Research Council
ID : 771486
Pays : International
Organisme : European Research Council
ID : 773208
Pays : International
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC001112
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001112
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Cancer Cell. 2015 Feb 9;27(2):177-92
pubmed: 25670079
Front Oncol. 2022 Sep 23;12:988872
pubmed: 36338708
Science. 2019 Feb 8;363(6427):644-649
pubmed: 30733421
Pharm Biol. 2014 Nov;52(11):1460-6
pubmed: 24963944
Sci Adv. 2021 Oct 08;7(41):eabh2443
pubmed: 34613780
Stem Cell Res. 2018 Dec;33:25-35
pubmed: 30308415
J Mass Spectrom. 1996 Mar;31(3):255-62
pubmed: 8799277
Cell Metab. 2019 Apr 2;29(4):886-900.e5
pubmed: 30661930
Nat Rev Mol Cell Biol. 2014 Aug;15(8):536-50
pubmed: 25053359
Cancer Res. 2021 Apr 15;81(8):1988-2001
pubmed: 33687947
J Lipid Res. 2014 Jul;55(7):1478-88
pubmed: 24859739
Bio Protoc. 2016 Nov 20;6(22):
pubmed: 28180137
J Clin Invest. 2004 Aug;114(4):569-81
pubmed: 15314694
Cell Rep. 2016 Mar 8;14(9):2154-2165
pubmed: 26923594
Breast Cancer Res. 2000;2(5):331-4
pubmed: 11250725
EMBO J. 2014 Sep 1;33(17):1912-27
pubmed: 25024434
Genes Dev. 2009 Apr 1;23(7):849-61
pubmed: 19339690
Nat Commun. 2018 Feb 5;9(1):493
pubmed: 29402958
Nat Commun. 2017 May 11;8:15267
pubmed: 28492237
Mol Cell. 2020 Jan 2;77(1):120-137.e9
pubmed: 31733993
Nat Protoc. 2011 Feb;6(2):147-57
pubmed: 21293456
Nature. 2019 Feb;566(7744):403-406
pubmed: 30728499
Biomed Pharmacother. 2018 Oct;106:1-7
pubmed: 29940537
Trends Biochem Sci. 2008 Jul;33(7):339-49
pubmed: 18585916
Methods Mol Biol. 2019;1862:53-66
pubmed: 30315459
Nature. 2020 Sep;585(7823):113-118
pubmed: 32814895
Biochem Biophys Res Commun. 2004 Nov 26;324(4):1204-9
pubmed: 15504342
Nature. 2019 Apr;568(7750):117-121
pubmed: 30814728
Methods Enzymol. 2016;574:3-29
pubmed: 27423855
Nat Rev Cancer. 2021 Mar;21(3):162-180
pubmed: 33462499
Cancers (Basel). 2021 Sep 24;13(19):
pubmed: 34638280
Cell Rep. 2016 Oct 11;17(3):837-848
pubmed: 27732858
Nature. 2021 Nov;599(7884):302-307
pubmed: 34671163
Cancer Cell. 2009 Jan 6;15(1):35-44
pubmed: 19111879
Cell Metab. 2021 Oct 5;33(10):2040-2058.e10
pubmed: 34559989
Cancer Discov. 2014 Apr;4(4):466-79
pubmed: 24513958
Mol Cancer Res. 2020 Jul;18(7):1088-1098
pubmed: 32198139
Curr Opin Biotechnol. 2015 Aug;34:189-201
pubmed: 25731751
Cell Metab. 2022 Nov 1;34(11):1675-1699
pubmed: 36261043
Biochem Biophys Res Commun. 2007 Jun 22;358(1):150-5
pubmed: 17467667
Clin Exp Metastasis. 2014 Jan;31(1):67-79
pubmed: 23963763
Nature. 2019 Aug;572(7771):603-608
pubmed: 31462798
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Science. 2020 Aug 7;369(6504):712-717
pubmed: 32527928
Cancer Res. 2012 Aug 15;72(16):3906-11
pubmed: 22751463
Clin Sci (Lond). 2021 Jan 15;135(1):231-257
pubmed: 33443284
Blood. 2022 Jan 20;139(3):384-398
pubmed: 34232979
Mol Cell. 2018 Aug 2;71(3):398-408
pubmed: 30075141
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
Biochem Cell Biol. 2019 Feb;97(1):30-45
pubmed: 29671337
Cancer Cell. 2016 Aug 8;30(2):243-256
pubmed: 27505671
Nat Cancer. 2020 Jun;1(6):603-619
pubmed: 34124690
Nature. 2021 Nov;599(7885):485-490
pubmed: 34759321
Front Oncol. 2019 Apr 24;9:219
pubmed: 31069166
iScience. 2021 Oct 07;24(11):103244
pubmed: 34746707
Oncotarget. 2016 Apr 12;7(15):19982-96
pubmed: 26799588
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Semin Cancer Biol. 2020 Feb;60:274-284
pubmed: 31491560
Nat Cancer. 2021 Apr;2(4):414-428
pubmed: 34179825
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Mol Cell. 2021 Jan 21;81(2):386-397.e7
pubmed: 33340488
Oncogene. 2018 Nov;37(46):6025-6040
pubmed: 29995871
Cell Metab. 2017 Dec 5;26(6):842-855.e5
pubmed: 29056512
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
NAR Cancer. 2021 Sep 09;3(3):zcab035
pubmed: 34514415
Oncogene. 2009 Aug 27;28(34):3022-32
pubmed: 19543317
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Lipids Health Dis. 2020 Jun 3;19(1):122
pubmed: 32493486
Nat Cell Biol. 2015 Feb;17(2):183-94
pubmed: 25621950
EMBO Rep. 2020 Oct 5;21(10):e50635
pubmed: 32964587
J Med Chem. 2009 Jan 22;52(2):530-6
pubmed: 19099397
Adv Bioinformatics. 2008;2008:420747
pubmed: 19956698
Nature. 2019 Feb;566(7745):496-502
pubmed: 30787437
Blood. 2019 Oct 17;134(16):1323-1336
pubmed: 31492675
Metab Eng. 2017 Sep;43(Pt B):187-197
pubmed: 27847310
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
Nat Rev Cancer. 2011 Nov 24;11(12):886-95
pubmed: 22113164
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Breast Cancer Res Treat. 2000 Jul;62(1):51-62
pubmed: 10989985
Cell Metab. 2018 Dec 4;28(6):881-894.e13
pubmed: 30146488
J Nutr. 2005 Aug;135(8):1841-6
pubmed: 16046706
Dev Cell. 2021 May 17;56(10):1363-1393
pubmed: 33945792
Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1370-5
pubmed: 19542021
J Clin Invest. 2013 Jul;123(7):3025-36
pubmed: 23921127
Nat Cell Biol. 2008 Nov;10(11):1349-55
pubmed: 18820689
Cell Rep. 2016 Nov 1;17(6):1463-1472
pubmed: 27806287
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
Anal Chem. 2003 Feb 1;75(3):663-70
pubmed: 12585499
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14635-40
pubmed: 16192349
Cell. 2015 Oct 8;163(2):506-19
pubmed: 26451490
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Bone. 2019 Jan;118:53-61
pubmed: 29258874

Auteurs

Patricia Altea-Manzano (P)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Ginevra Doglioni (G)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Yawen Liu (Y)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, China.

Alejandro M Cuadros (AM)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Emma Nolan (E)

The Francis Crick Institute, London, UK.

Juan Fernández-García (J)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Qi Wu (Q)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.

Mélanie Planque (M)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Kathrin Julia Laue (KJ)

Department of Human Molecular Genetics & Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Florencia Cidre-Aranaz (F)

Hopp-Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

Xiao-Zheng Liu (XZ)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Oskar Marin-Bejar (O)

Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
Department of Oncology, KU Leuven, Leuven, Belgium.

Joke Van Elsen (J)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Ines Vermeire (I)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Dorien Broekaert (D)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Sofie Demeyer (S)

Laboratory for Molecular Biology of Leukemia, VIB-KU Leuven, Leuven, Belgium.

Xander Spotbeen (X)

Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.

Jakub Idkowiak (J)

Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.
Department of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic.

Aurélie Montagne (A)

Université Paris Cité, NF-kappaB, Différenciation et Cancer, Paris, France.

Margherita Demicco (M)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

H Furkan Alkan (HF)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Nick Rabas (N)

The Francis Crick Institute, London, UK.

Carla Riera-Domingo (C)

Laboratory of Tumor Inflammation and Angiogenesis, VIB Center for Cancer Biology, Leuven, Belgium.
Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.

François Richard (F)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Tatjana Geukens (T)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Maxim De Schepper (M)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Sophia Leduc (S)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Sigrid Hatse (S)

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.

Yentl Lambrechts (Y)

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.

Emily Jane Kay (EJ)

Cancer Research UK Beatson Institute, Glasgow, UK.

Sergio Lilla (S)

Cancer Research UK Beatson Institute, Glasgow, UK.

Alisa Alekseenko (A)

SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Solna, Sweden.

Vincent Geldhof (V)

Laboratory for Angiogenesis and Vascular Metabolism, VIB-KU Leuven, Leuven, Belgium.

Bram Boeckx (B)

Laboratory of Translational Genetics, VIB Center for Cancer Biology, Leuven, Belgium.
Laboratory of Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.

Celia de la Calle Arregui (C)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.

Giuseppe Floris (G)

Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven, Leuven, Belgium.
Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Johannes V Swinnen (JV)

Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven, Leuven, Belgium.

Jean-Christophe Marine (JC)

Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, Leuven, Belgium.
Department of Oncology, KU Leuven, Leuven, Belgium.

Diether Lambrechts (D)

Laboratory of Translational Genetics, VIB Center for Cancer Biology, Leuven, Belgium.
Laboratory of Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.

Vicent Pelechano (V)

SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Solna, Sweden.

Massimiliano Mazzone (M)

Laboratory of Tumor Inflammation and Angiogenesis, VIB Center for Cancer Biology, Leuven, Belgium.
Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.

Sara Zanivan (S)

Cancer Research UK Beatson Institute, Glasgow, UK.
School of Cancer Sciences, University of Glasgow, Glasgow, UK.

Jan Cools (J)

Laboratory for Molecular Biology of Leukemia, VIB-KU Leuven, Leuven, Belgium.

Hans Wildiers (H)

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.

Véronique Baud (V)

Université Paris Cité, NF-kappaB, Différenciation et Cancer, Paris, France.

Thomas G P Grünewald (TGP)

Hopp-Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

Uri Ben-David (U)

Department of Human Molecular Genetics & Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Christine Desmedt (C)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Ilaria Malanchi (I)

The Francis Crick Institute, London, UK.

Sarah-Maria Fendt (SM)

Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium. sarah-maria.fendt@kuleuven.be.
Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium. sarah-maria.fendt@kuleuven.be.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH